Expressing the sense of Congress regarding the need for further study of the neurological disorder dysnia.
The source supplies the latest action, but no lifecycle stage.
Latest action (25 Jul 2007): Referred to the Subcommittee on Health.
What this bill does
This resolution, H.Con.Res. 192, expresses the sense of Congress that the Director of the National Institutes of Health (NIH) should play a leading role in addressing dystonia. It calls for continued collaboration among specific NIH institutes on dystonia research, encourages funding for research and education, and suggests exploring research opportunities at the John Edward Porter Neuroscience Research Center. The resolution also advocates for increased funding for basic biomedical research, the development of an accurate diagnostic test, improved patient access to therapies, and enhanced public awareness and professional education about dystonia.
Dystonia is described as a neurological disorder causing involuntary muscle spasms, leading to twisting movements and postural deformities. It can affect individuals of all ages and backgrounds, is the third most common movement disorder, and impacts an estimated 300,000 people in North America. The resolution notes that there is currently no cure for dystonia, and existing treatments only manage symptoms.
This concurrent resolution was introduced in the House of Representatives in July 2007 by Representative Danny K. Davis. It was then referred to the House Committee on Energy and Commerce and subsequently to its Subcommittee on Health. As a concurrent resolution, if passed by both the House and Senate, it would express the collective sentiment of Congress, but it does not have the force of law and does not require the President's signature.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Official summary
Urges the Director of the National Institutes of Health (NIH) to take a leadership role in the fight against the neurological disorder dystonia.
Calls for: (1) increased funding for basic biomedical research for dystonia and other neurological disorders through NIH; (2) additional research to identify an accurate diagnostic test for dystonia and an epidemiological study to determine the frequency of the disease; (3) improved patient access to safe and effective dystonia therapies; and (4) increased public awareness and professional education regarding dystonia through partnerships between the government and patient advocacy organizations.
Timeline
25 Jul 2007
Referred to the Subcommittee on Health.
Common questions
- What does H.Con.Res. 192 do?
- This resolution, H.Con.Res. 192, expresses the sense of Congress that the Director of the National Institutes of Health (NIH) should play a leading role in addressing dystonia. It calls for continued collaboration among specific NIH institutes on dystonia research, encourages funding for research and education, and suggests exploring research opportunities at the John Edward Porter Neuroscience Research Center. The resolution also advocates for increased funding for basic biomedical research, the development of an accurate diagnostic test, improved patient access to therapies, and enhanced public awareness and professional education about dystonia. Dystonia is described as a neurological disorder causing involuntary muscle spasms, leading to twisting movements and postural deformities. It can affect individuals of all ages and backgrounds, is the third most common movement disorder, and impacts an estimated 300,000 people in North America. The resolution notes that there is currently no cure for dystonia, and existing treatments only manage symptoms. This concurrent resolution was introduced in the House of Representatives in July 2007 by Representative Danny K. Davis. It was then referred to the House Committee on Energy and Commerce and subsequently to its Subcommittee on Health. As a concurrent resolution, if passed by both the House and Senate, it would express the collective sentiment of Congress, but it does not have the force of law and does not require the President's signature.
- Has H.Con.Res. 192 become law?
- The source does not supply a confirmed lifecycle stage for H.Con.Res. 192. Check the latest action and official source below.
- Who sponsored H.Con.Res. 192?
- H.Con.Res. 192 was sponsored by Rep. Davis, Danny K. [D-IL-7] (D-IL), with 0 cosponsors.
- What's the latest action on H.Con.Res. 192?
- Referred to the Subcommittee on Health. (25 Jul 2007).
Related bills in Health
Choices for Increased Mobility Act of 2026
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
Access to Medical Supplies Act
Lower Premiums, Faster Payments Act
More bills from Rep. Davis, Danny K. [D-IL-7]
Of inquiry requesting the President and directing the Secretary of Health and Human Services to transmit, respectively, certain documents to the House of Representatives relating to the effect on taxpayer and child privacy of the seizure by the so-called "Department of Government Efficiency" of legally-protected identity and financial data stored in the National Directory of New Hires and the Federal Parent Locator Service.
Computer and Internet Access Equity Act
Supporting the goals and ideals of National Sarcoidosis Awareness Month in April 2010 and supporting efforts to devote new resources to research the causes of the disease, environmental and otherwise, along with treatments and workforce strategies to support individuals with sarcoidosis and their families.
Supporting the goals and ideals of Sickle Cell Disease Awareness Month.
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.